APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Microbiology Rapid Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Microbiology Rapid Testing Market Outlook and Growth Opportunities 2026

6 March 2026197 pages

Choose your research edition.

Industry ResearchPharmaceutical Microbiology Rapid Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Microbiology Rapid Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Microbiology Rapid Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Microbiology Rapid Testing Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Microbiology Rapid Testing Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pharmaceutical Microbiology Rapid Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Microbiology Rapid Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Microbiology Rapid Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Microbiology Rapid Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Microbiology Rapid Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Microbiology Rapid Testing market include Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., Virbac, Ceva Sante Animale, CZ Vaccines S.A.U. (Zendal Health S.A.) and Indian Immunologicals Ltd. (National Dairy Development Board), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Microbiology Rapid Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Microbiology Rapid Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Microbiology Rapid Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Microbiology Rapid Testing market.

Pharmaceutical Microbiology Rapid Testing Segment by Company

Boehringer Ingelheim International GmbH

Zoetis, Inc.

Merck & Co., Inc.

Bimeda, Inc.

Elanco Animal Health, Inc.

Virbac

Ceva Sante Animale

CZ Vaccines S.A.U. (Zendal Health S.A.)

Indian Immunologicals Ltd. (National Dairy Development Board)

Vaxxinova International BV (EW Group)

Pharmaceutical Microbiology Rapid Testing Segment by Type

Instruments

Reagents & Kits

Consumables

Pharmaceutical Microbiology Rapid Testing Segment by Application

Biopharmaceutical Company

Hospital

Others

Pharmaceutical Microbiology Rapid Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Microbiology Rapid Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Microbiology Rapid Testing key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Microbiology Rapid Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Microbiology Rapid Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Microbiology Rapid Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Microbiology Rapid Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Microbiology Rapid Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Microbiology Rapid Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Microbiology Rapid Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Microbiology Rapid Testing industry.

Chapter 3: Detailed analysis of Pharmaceutical Microbiology Rapid Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Microbiology Rapid Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Microbiology Rapid Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Microbiology Rapid Testing Industry Trends Table 2. Pharmaceutical Microbiology Rapid Testing Industry Drivers Table 3. Pharmaceutical Microbiology Rapid Testing Industry Opportunities and Challenges Table 4. Pharmaceutical Microbiology Rapid Testing Industry Restraints Table 5. Global Pharmaceutical Microbiology Rapid Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Microbiology Rapid Testing Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Microbiology Rapid Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Microbiology Rapid Testing Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Microbiology Rapid Testing Company, Product Type & Application Table 10. Global Pharmaceutical Microbiology Rapid Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Microbiology Rapid Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Instruments Table 15. Significant Companies of Reagents & Kits Table 16. Significant Companies of Consumables Table 17. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type (2021-2026) Table 21. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Biopharmaceutical Company Table 23. Significant Companies of Hospital Table 24. Significant Companies of Others Table 25. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application (2021-2026) Table 29. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application (2027-2032) Table 30. Global Pharmaceutical Microbiology Rapid Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Region (2021-2026) Table 33. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Region (2027-2032) Table 35. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pharmaceutical Microbiology Rapid Testing Sales Value Market Share by Country (2021-2026) Table 38. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pharmaceutical Microbiology Rapid Testing Sales Value Market Share by Country (2027-2032) Table 40. Boehringer Ingelheim International GmbH Company Information Table 41. Boehringer Ingelheim International GmbH Business Overview Table 42. Boehringer Ingelheim International GmbH Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Boehringer Ingelheim International GmbH Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 44. Boehringer Ingelheim International GmbH Recent Development Table 45. Zoetis, Inc. Company Information Table 46. Zoetis, Inc. Business Overview Table 47. Zoetis, Inc. Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Zoetis, Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 49. Zoetis, Inc. Recent Development Table 50. Merck & Co., Inc. Company Information Table 51. Merck & Co., Inc. Business Overview Table 52. Merck & Co., Inc. Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Merck & Co., Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 54. Merck & Co., Inc. Recent Development Table 55. Bimeda, Inc. Company Information Table 56. Bimeda, Inc. Business Overview Table 57. Bimeda, Inc. Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Bimeda, Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 59. Bimeda, Inc. Recent Development Table 60. Elanco Animal Health, Inc. Company Information Table 61. Elanco Animal Health, Inc. Business Overview Table 62. Elanco Animal Health, Inc. Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Elanco Animal Health, Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 64. Elanco Animal Health, Inc. Recent Development Table 65. Virbac Company Information Table 66. Virbac Business Overview Table 67. Virbac Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Virbac Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 69. Virbac Recent Development Table 70. Ceva Sante Animale Company Information Table 71. Ceva Sante Animale Business Overview Table 72. Ceva Sante Animale Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Ceva Sante Animale Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 74. Ceva Sante Animale Recent Development Table 75. CZ Vaccines S.A.U. (Zendal Health S.A.) Company Information Table 76. CZ Vaccines S.A.U. (Zendal Health S.A.) Business Overview Table 77. CZ Vaccines S.A.U. (Zendal Health S.A.) Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. CZ Vaccines S.A.U. (Zendal Health S.A.) Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 79. CZ Vaccines S.A.U. (Zendal Health S.A.) Recent Development Table 80. Indian Immunologicals Ltd. (National Dairy Development Board) Company Information Table 81. Indian Immunologicals Ltd. (National Dairy Development Board) Business Overview Table 82. Indian Immunologicals Ltd. (National Dairy Development Board) Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Indian Immunologicals Ltd. (National Dairy Development Board) Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 84. Indian Immunologicals Ltd. (National Dairy Development Board) Recent Development Table 85. Vaxxinova International BV (EW Group) Company Information Table 86. Vaxxinova International BV (EW Group) Business Overview Table 87. Vaxxinova International BV (EW Group) Pharmaceutical Microbiology Rapid Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Vaxxinova International BV (EW Group) Pharmaceutical Microbiology Rapid Testing Product Portfolio Table 89. Vaxxinova International BV (EW Group) Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Pharmaceutical Microbiology Rapid Testing Product Image Figure 2. Global Pharmaceutical Microbiology Rapid Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Microbiology Rapid Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Microbiology Rapid Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Instruments Image Figure 8. Reagents & Kits Image Figure 9. Consumables Image Figure 10. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type (2021-2032) Figure 13. Biopharmaceutical Company Image Figure 14. Hospital Image Figure 15. Others Image Figure 16. Global Pharmaceutical Microbiology Rapid Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application (2021-2032) Figure 19. Global Pharmaceutical Microbiology Rapid Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Instruments
  • Reagents & Kits
  • Consumables
Applications
  • Biopharmaceutical Company
  • Hospital
  • Others
Companies covered
  • Boehringer Ingelheim International GmbH
  • Zoetis, Inc.
  • Merck & Co., Inc.
  • Bimeda, Inc.
  • Elanco Animal Health, Inc.
  • Virbac
  • Ceva Sante Animale
  • CZ Vaccines S.A.U. (Zendal Health S.A.)
  • Indian Immunologicals Ltd. (National Dairy Development Board)
  • Vaxxinova International BV (EW Group)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Microbiology Rapid Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Microbiology Rapid Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Microbiology Rapid Testing Market Dynamics
  1. 2.1 Pharmaceutical Microbiology Rapid Testing Industry Trends
  2. 2.2 Pharmaceutical Microbiology Rapid Testing Industry Drivers
  3. 2.3 Pharmaceutical Microbiology Rapid Testing Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Microbiology Rapid Testing Industry Restraints
3 Pharmaceutical Microbiology Rapid Testing Market by Company
  1. 3.1 Global Pharmaceutical Microbiology Rapid Testing Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Microbiology Rapid Testing Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Microbiology Rapid Testing Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Microbiology Rapid Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Microbiology Rapid Testing Company Product Type and Application
  6. 3.6 Global Pharmaceutical Microbiology Rapid Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Microbiology Rapid Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Microbiology Rapid Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Microbiology Rapid Testing Market by Type
  1. 4.1 Pharmaceutical Microbiology Rapid Testing Type Introduction
  2. 4.1.1 Instruments
  3. 4.1.2 Reagents & Kits
  4. 4.1.3 Consumables
  5. 4.2 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Type
  6. 4.2.1 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type (2021-2032)
5 Pharmaceutical Microbiology Rapid Testing Market by Application
  1. 5.1 Pharmaceutical Microbiology Rapid Testing Application Introduction
  2. 5.1.1 Biopharmaceutical Company
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Application
  6. 5.2.1 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application (2021-2032)
6 Pharmaceutical Microbiology Rapid Testing Regional Value Analysis
  1. 6.1 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Microbiology Rapid Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Microbiology Rapid Testing Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Microbiology Rapid Testing Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Microbiology Rapid Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Microbiology Rapid Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Microbiology Rapid Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Microbiology Rapid Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim International GmbH
  2. 8.1.1 Boehringer Ingelheim International GmbH Company Information
  3. 8.1.2 Boehringer Ingelheim International GmbH Business Overview
  4. 8.1.3 Boehringer Ingelheim International GmbH Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim International GmbH Pharmaceutical Microbiology Rapid Testing Product Portfolio
  6. 8.1.5 Boehringer Ingelheim International GmbH Recent Developments
  7. 8.2 Zoetis, Inc.
  8. 8.2.1 Zoetis, Inc. Company Information
  9. 8.2.2 Zoetis, Inc. Business Overview
  10. 8.2.3 Zoetis, Inc. Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis, Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio
  12. 8.2.5 Zoetis, Inc. Recent Developments
  13. 8.3 Merck & Co., Inc.
  14. 8.3.1 Merck & Co., Inc. Company Information
  15. 8.3.2 Merck & Co., Inc. Business Overview
  16. 8.3.3 Merck & Co., Inc. Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co., Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio
  18. 8.3.5 Merck & Co., Inc. Recent Developments
  19. 8.4 Bimeda, Inc.
  20. 8.4.1 Bimeda, Inc. Company Information
  21. 8.4.2 Bimeda, Inc. Business Overview
  22. 8.4.3 Bimeda, Inc. Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bimeda, Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio
  24. 8.4.5 Bimeda, Inc. Recent Developments
  25. 8.5 Elanco Animal Health, Inc.
  26. 8.5.1 Elanco Animal Health, Inc. Company Information
  27. 8.5.2 Elanco Animal Health, Inc. Business Overview
  28. 8.5.3 Elanco Animal Health, Inc. Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Animal Health, Inc. Pharmaceutical Microbiology Rapid Testing Product Portfolio
  30. 8.5.5 Elanco Animal Health, Inc. Recent Developments
  31. 8.6 Virbac
  32. 8.6.1 Virbac Company Information
  33. 8.6.2 Virbac Business Overview
  34. 8.6.3 Virbac Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Virbac Pharmaceutical Microbiology Rapid Testing Product Portfolio
  36. 8.6.5 Virbac Recent Developments
  37. 8.7 Ceva Sante Animale
  38. 8.7.1 Ceva Sante Animale Company Information
  39. 8.7.2 Ceva Sante Animale Business Overview
  40. 8.7.3 Ceva Sante Animale Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ceva Sante Animale Pharmaceutical Microbiology Rapid Testing Product Portfolio
  42. 8.7.5 Ceva Sante Animale Recent Developments
  43. 8.8 CZ Vaccines S.A.U. (Zendal Health S.A.)
  44. 8.8.1 CZ Vaccines S.A.U. (Zendal Health S.A.) Company Information
  45. 8.8.2 CZ Vaccines S.A.U. (Zendal Health S.A.) Business Overview
  46. 8.8.3 CZ Vaccines S.A.U. (Zendal Health S.A.) Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CZ Vaccines S.A.U. (Zendal Health S.A.) Pharmaceutical Microbiology Rapid Testing Product Portfolio
  48. 8.8.5 CZ Vaccines S.A.U. (Zendal Health S.A.) Recent Developments
  49. 8.9 Indian Immunologicals Ltd. (National Dairy Development Board)
  50. 8.9.1 Indian Immunologicals Ltd. (National Dairy Development Board) Company Information
  51. 8.9.2 Indian Immunologicals Ltd. (National Dairy Development Board) Business Overview
  52. 8.9.3 Indian Immunologicals Ltd. (National Dairy Development Board) Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Indian Immunologicals Ltd. (National Dairy Development Board) Pharmaceutical Microbiology Rapid Testing Product Portfolio
  54. 8.9.5 Indian Immunologicals Ltd. (National Dairy Development Board) Recent Developments
  55. 8.10 Vaxxinova International BV (EW Group)
  56. 8.10.1 Vaxxinova International BV (EW Group) Company Information
  57. 8.10.2 Vaxxinova International BV (EW Group) Business Overview
  58. 8.10.3 Vaxxinova International BV (EW Group) Pharmaceutical Microbiology Rapid Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Vaxxinova International BV (EW Group) Pharmaceutical Microbiology Rapid Testing Product Portfolio
  60. 8.10.5 Vaxxinova International BV (EW Group) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst